Mark Cuban Value Plus Drug Firm (MCCPDC) introduced it’s working with Coherus Biosciences, Inc. to promote Yusimry, a biosimilar model of the top-selling drug Humira, at a reduced value.
Yusimry is used to deal with a number of ailments, akin to rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s illness and plaque psoriasis.
The remedy will likely be out there by way of MCCPDC beginning July 2023, costing $569.27 plus shelling out and delivery charges. Will probably be the primary biologic product provided by the low cost drug provider.
In February, MCCPDC introduced a brand new program on Twitter, aiming to create an unbiased pharmacists’ community the place members could be offered a “Workforce Cuban Advantages Card.” MCCPDC mentioned in a press release that Yusimry could be included in the advantages program by way of collaborating pharmacies.
“Coherus’s Yusimry is a recreation changer. Having an alternative choice to Humira that’s inexpensive will enhance the lives of sufferers in all places. Costplusdrugs.com is actually excited to make Yusimry out there to everybody in a clear method,” Mark Cuban advised MobiHealthNews in an electronic mail.
THE LARGER TREND
Since MCCPDC’s launch in 2022, it is developed quite a few partnerships and collaborations.
In April, the corporate introduced a collaboration with Seattle-based Zócalo Well being, a digital healthcare service for Latino sufferers, to develop Zócalo members’ entry to lower-cost prescription remedy.
That very same month, Fierce Healthcare reported MCCPDC teamed up with RevSpring, a well being cost options firm, to run a program with U.S. pharmacies to make medicine extra inexpensive for shoppers.
MCCPDC has additionally established partnerships with California-based EmsanaRx and Tennessee-based RxPreferred Advantages and introduced collaborations with diabetes and power illness administration firm Diathrive Well being and most cancers care help firm OncoPower.
MCCPDC was additionally built-in into Rightway Well being‘s platform, permitting the pharmacy profit supervisor’s members entry to MCCPDC.
Final 12 months, the corporate additionally introduced its first well being plan partnership with Capital Blue Cross, noting Capital’s members may use their insurance coverage playing cards at MCCPDC instantly as of the beginning of 2023.